236 related articles for article (PubMed ID: 25999521)
1. Seroprevalence of 10 human papillomavirus types in the general rural population of Anyang, China: a cross-sectional study.
Zhang C; Liu F; Deng Q; He Z; Xi L; Liu Y; Pan Y; Ning T; Guo C; Xu R; Zhang L; Cai H; Ke Y
Sex Transm Infect; 2015 Nov; 91(7):506-9. PubMed ID: 25999521
[TBL] [Abstract][Full Text] [Related]
2. Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening program.
Učakar V; Jelen MM; Faust H; Poljak M; Dillner J; Klavs I
Vaccine; 2013 Oct; 31(43):4935-9. PubMed ID: 23994822
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of seven high-risk HPV types in The Netherlands.
Scherpenisse M; Mollers M; Schepp RM; Boot HJ; de Melker HE; Meijer CJ; Berbers GA; van der Klis FR
Vaccine; 2012 Oct; 30(47):6686-93. PubMed ID: 22959981
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.
Ji J; Sun HK; Smith JS; Wang H; Esser MT; Hu S; Pretorius RG; Chen W; Belinson JL; Qiao YL
BMC Infect Dis; 2012 Jun; 12():137. PubMed ID: 22715915
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida.
Iannacone MR; Michael KM; Giuliano AR; Waterboer T; Pawlita M; Rollison DE
J Infect Dis; 2010 Mar; 201(5):760-9. PubMed ID: 20105078
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus DNA positivity and seropositivity in rural Chinese men and women: a population-based cross-sectional study.
Liu F; Deng Q; Zhang C; Pan Y; Liu Y; He Z; Sun M; Liu M; Li J; Li X; Zhang C; Hang D; Ning T; Guo C; Liang Y; Xu R; Zhang L; Cai H; Ke Y
Sci Rep; 2016 May; 6():26343. PubMed ID: 27211017
[TBL] [Abstract][Full Text] [Related]
7. Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands.
Scherpenisse M; Mollers M; Schepp RM; Boot HJ; Meijer CJ; Berbers GA; van der Klis FR; de Melker HE
PLoS One; 2012; 7(11):e48807. PubMed ID: 23152809
[TBL] [Abstract][Full Text] [Related]
8. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States.
Thompson DL; Douglas JM; Foster M; Hagensee ME; Diguiseppi C; Barón AE; Cameron JE; Spencer TC; Zenilman J; Malotte CK; Bolan G; Kamb ML; Peterman TA;
J Infect Dis; 2004 Nov; 190(9):1563-74. PubMed ID: 15478060
[TBL] [Abstract][Full Text] [Related]
9. Mucosal and cutaneous Human Papillomavirus seroprevalence among adults in the prevaccine era in Germany - Results from a nationwide population-based survey.
Loenenbach AD; Poethko-Müller C; Pawlita M; Thamm M; Harder T; Waterboer T; Schröter J; Deleré Y; Wichmann O; Wiese-Posselt M
Int J Infect Dis; 2019 Jun; 83():3-11. PubMed ID: 30904676
[TBL] [Abstract][Full Text] [Related]
10. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.
Newall AT; Brotherton JM; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR
Clin Infect Dis; 2008 Jun; 46(11):1647-55. PubMed ID: 18444790
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.
Markowitz LE; Sternberg M; Dunne EF; McQuillan G; Unger ER
J Infect Dis; 2009 Oct; 200(7):1059-67. PubMed ID: 19719390
[TBL] [Abstract][Full Text] [Related]
12. Skin and mucosal human papillomavirus seroprevalence in persons with Fanconi Anemia.
Katzenellenbogen RA; Carter JJ; Stern JE; Butsch Kovacic MS; Mehta PA; Sauter SL; Galloway DA; Winer RL
Clin Vaccine Immunol; 2015 Apr; 22(4):413-20. PubMed ID: 25651924
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana.
Firnhaber C; Evans D; Friedman-Khalili R; Willliams S; Michelow P; Matlhagela K; Wester C; Grinsztejn B; Lockman S
J Clin Virol; 2011 Nov; 52(3):265-8. PubMed ID: 21908233
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study.
Rahman S; Pierce Campbell CM; Rollison DE; Wang W; Waterboer T; Michel A; Pawlita M; Villa LL; Lazcano Ponce E; Borenstein AR; Giuliano AR
PLoS One; 2016; 11(11):e0167173. PubMed ID: 27902759
[TBL] [Abstract][Full Text] [Related]
15. Age-specific seroprevalence of human papillomavirus 16, 18, 31, and 58 in women of a rural town of Colombia.
Bedoya AM; Gaviria AM; Baena A; Borrero M; Duarte DF; Combita AL; Castaño J; Grisales H; Sánchez GI
Int J Gynecol Cancer; 2012 Feb; 22(2):303-10. PubMed ID: 22228426
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes.
Touzé A; de Sanjosé S; Coursaget P; Almirall MR; Palacio V; Meijer CJ; Kornegay J; Bosch FX
J Clin Microbiol; 2001 Dec; 39(12):4344-8. PubMed ID: 11724843
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence.
Kreimer AR; Alberg AJ; Viscidi R; Gillison ML
Sex Transm Dis; 2004 Apr; 31(4):247-56. PubMed ID: 15028941
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico.
Ortiz AP; Tortolero-Luna G; Romaguera J; Pérez CM; González D; Muñoz C; González L; Marrero E; Suárez E; Palefsky JM; Panicker G; Unger ER
Papillomavirus Res; 2018 Jun; 5():109-113. PubMed ID: 29555601
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of human papillomavirus type 16 in children.
Dunne EF; Karem KL; Sternberg MR; Stone KM; Unger ER; Reeves WC; Markowitz LE
J Infect Dis; 2005 Jun; 191(11):1817-9. PubMed ID: 15871113
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men: a serological study.
Höpfl R; Petter A; Thaler P; Sarcletti M; Widschwendter A; Zangerle R
BMC Infect Dis; 2003 Apr; 3():6. PubMed ID: 12723991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
